Durvalumab

Advaxis AIO Studien gGmbH AstraZeneca Big Ten Cancer Research Consortium Canadian Cancer Trials Group Case Comprehensive Cancer Center Celgene International SARL Centre hospitalier de l'Universite de Montreal Centre Leon Berard Charite - Universitatsmedizin Berlin Childrens Hospital Los Angeles Dana-Farber Cancer Institute Eli Lilly Fondazione IRCCS Istituto Nazionale dei Tumori GlaxoSmithKline Gradalis Grand Hopital de Charleroi Grupo Espanol de Tumores Neuroendocrinos Gustave Roussy Immunocore Innate Pharma Institut Claudius Regaud Juno Therapeutics Kyoto Breast Cancer Research Network Ludwig Institute for Cancer Research M. D. Anderson Cancer Center MedImmune Memorial Sloan-Kettering Cancer Center Mirati Therapeutics Myriad Genetic Laboratories National Cancer Institute (USA) National Health and Medical Research Council Northwestern University Pharmacyclics Plexxikon Radboud University Samsung Medical Center Spanish Oncology Genito-Urinary Group Swiss Group for Clinical Cancer Research UNC Lineberger Comprehensive Cancer Center UNICANCER University College London University of Colorado at Denver University of Kansas Medical Center University of Maryland Greenbaum Cancer Center University of Southern California University of Sydney University of Texas M. D. Anderson Cancer Center VentiRx Pharmaceuticals Washington University School of Medicine Yale University Yonsei University College of Medicine

Imfinzi MEDI-4736 MEDI4736